Examining the Role of Matrix Metalloproteinase-2 and MicroRNAs Regulation in Breast Cancer

Elmira Aboutalebi Vand Beilankouhi1, Niloufar Kheradi2, Yosra Vaez-Gharamaleki3

  • 1Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, East Azerbaijan, Iran.

The Breast Journal
|December 8, 2025
PubMed

Insights

MicroRNAs (miRNAs) regulate matrix metalloproteinase-2 (MMP-2) expression, impacting breast cancer (BC) cell invasion and metastasis. Understanding these miRNA-MMP-2 interactions offers new therapeutic targets for BC management.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Matrix metalloproteinases (MMPs), particularly MMP-2, are crucial in cancer cell invasion and metastasis.
  • MicroRNAs (miRNAs) are noncoding RNAs that regulate gene expression, including that of MMP-2.
  • Emerging evidence suggests a significant regulatory relationship between miRNAs and MMP-2 in various cancers.

Purpose of the Study:

  • To investigate the intricate relationship between specific miRNAs and MMP-2 expression in breast cancer (BC).
  • To elucidate the molecular mechanisms by which miRNAs influence MMP-2 activity and its role in BC progression.
  • To identify potential miRNA-based therapeutic targets for controlling BC invasion and metastasis.

Main Methods:

  • Analysis of miRNA binding to the 3' untranslated region (3' UTR) of MMP-2 mRNA.
  • Assessment of changes in MMP-2 expression and enzymatic activity in response to miRNA modulation.
  • Correlation studies between specific miRNA expression levels and MMP-2 activity in BC cell lines.

Main Results:

  • Demonstrated that miRNAs can directly regulate MMP-2 expression and enzymatic activity by targeting its 3' UTR.
  • Observed that altered miRNA expression, such as decreased miR-106b, leads to increased MMP-2 levels and enhanced BC cell invasion.
  • Established a functional link between specific miRNAs and MMP-2 in driving key aspects of breast cancer progression.

Conclusions:

  • MiRNA-mediated regulation of MMP-2 is a critical factor in breast cancer invasion and metastasis.
  • Targeting the miRNA-MMP-2 axis presents a promising strategy for developing novel BC therapies.
  • Further research into these regulatory networks will deepen our understanding of BC pathogenesis and inform treatment development.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K